<DOC>
	<DOCNO>NCT02413541</DOCNO>
	<brief_summary>This research project study immunology change critically ill patient severe sepsis use Endotoxin Activity Assay ( EAA ) combine Polymyxin-B Hemoperfusion .</brief_summary>
	<brief_title>The Pilot Study Efficacy Polymyxin-B Hemoperfusion Critically Ill Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<criteria>SIRS Criteria &gt; = 2 meet definition Source infection &gt; = 1 meet definition Evidence organ dysfunction &gt; = 1 meet definition WBC &lt; 5,000 /ul Platelet &lt; 30,000 / ul Pregnancy woman Advance stage cancer patient ( terminally ill ) refuse resuscitate Received blood transfusion &gt; 5 unit 24 hr Allergy PolymyxinB High risk uncontrolled bleed Organ transplant patient On immunosuppressive agent within 2 week study HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>